Global Opioids Drugs Market Intelligence Report for Comprehensive Information 2018-2025

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Oct-2018   |    Format :PDF   |    Number of Pages : 110
In 2017, the global Opioids Drugs market size was  million US$ and is forecast to  million US in 2025, growing at a CAGR of  from 2018. The objectives of this study are to define, segment, and project the size of the Opioids Drugs market based on company, product type, application and key regions.

This report studies the global market size of Opioids Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioids Drugs in these regions.
This research report categorizes the global Opioids Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Opioids Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Opioids Drugs include
    Purdue Pharma
    J&J
    Teva
    Mylan
    Depomed
    INSYS
    Endo
    Pfizer
    Hikma
    Mallinckrodt
    Pernix
    Egalet
    Vistapharm

Market Size Split by Type
    Oxycodone
    Hydromorphone
    Codeine
    Fentanyl
    Other
Market Size Split by Application
    Pain Relief
    Anesthesia
    Other

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Opioids Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Opioids Drugs market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Opioids Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Opioids Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Opioids Drugs submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Opioids Drugs are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioids Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Opioids Drugs Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Opioids Drugs Market Size Growth Rate by Type
        1.4.2 Oxycodone
        1.4.3 Hydromorphone
        1.4.4 Codeine
        1.4.5 Fentanyl
        1.4.6 Other
    1.5 Market by Application
        1.5.1 Global Opioids Drugs Market Size Growth Rate by Application
        1.5.2 Pain Relief
        1.5.3 Anesthesia
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Opioids Drugs Market Size
        2.1.1 Global Opioids Drugs Revenue 2016-2025
        2.1.2 Global Opioids Drugs Sales 2016-2025
    2.2 Opioids Drugs Growth Rate by Regions
        2.2.1 Global Opioids Drugs Sales by Regions
        2.2.2 Global Opioids Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Opioids Drugs Sales by Manufacturers
        3.1.1 Opioids Drugs Sales by Manufacturers
        3.1.2 Opioids Drugs Sales Market Share by Manufacturers
        3.1.3 Global Opioids Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Opioids Drugs Revenue by Manufacturers
        3.2.1 Opioids Drugs Revenue by Manufacturers (2016-2018)
        3.2.2 Opioids Drugs Revenue Share by Manufacturers (2016-2018)
    3.3 Opioids Drugs Price by Manufacturers
    3.4 Opioids Drugs Manufacturing Base Distribution, Product Types
        3.4.1 Opioids Drugs Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Opioids Drugs Product Category
        3.4.3 Date of International Manufacturers Enter into Opioids Drugs  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Opioids Drugs Sales by Type
    4.2 Global Opioids Drugs Revenue by Type
    4.3 Opioids Drugs Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Opioids Drugs Breakdown Data by Application

6 North America
    6.1 North America Opioids Drugs by Countries
        6.1.1 North America Opioids Drugs Sales by Countries
        6.1.2 North America Opioids Drugs Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Opioids Drugs by Type
    6.3 North America Opioids Drugs by Application
    6.4 North America Opioids Drugs by Company

7 Europe
    7.1 Europe Opioids Drugs by Countries
        7.1.1 Europe Opioids Drugs Sales by Countries
        7.1.2 Europe Opioids Drugs Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Opioids Drugs by Type
    7.3 Europe Opioids Drugs by Application
    7.4 Europe Opioids Drugs by Company

8 Asia Pacific
    8.1 Asia Pacific Opioids Drugs by Countries
        8.1.1 Asia Pacific Opioids Drugs Sales by Countries
        8.1.2 Asia Pacific Opioids Drugs Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Opioids Drugs by Type
    8.3 Asia Pacific Opioids Drugs by Application
    8.4 Asia Pacific Opioids Drugs by Company

9 Central & South America
    9.1 Central & South America Opioids Drugs by Countries
        9.1.1 Central & South America Opioids Drugs Sales by Countries
        9.1.2 Central & South America Opioids Drugs Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Opioids Drugs by Type
    9.3 Central & South America Opioids Drugs by Application
    9.4 Central & South America Opioids Drugs by Company

10 Middle East and Africa
    10.1 Middle East and Africa Opioids Drugs by Countries
        10.1.1 Middle East and Africa Opioids Drugs Sales by Countries
        10.1.2 Middle East and Africa Opioids Drugs Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Opioids Drugs by Type
    10.3 Middle East and Africa Opioids Drugs by Application
    10.4 Middle East and Africa Opioids Drugs by Company

11 Company Profiles
    11.1 Purdue Pharma
        11.1.1 Purdue Pharma Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.1.4 Opioids Drugs Product Description
        11.1.5 Recent Development
    11.2 J&J
        11.2.1 J&J Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.2.4 Opioids Drugs Product Description
        11.2.5 Recent Development
    11.3 Teva
        11.3.1 Teva Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.3.4 Opioids Drugs Product Description
        11.3.5 Recent Development
    11.4 Mylan
        11.4.1 Mylan Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.4.4 Opioids Drugs Product Description
        11.4.5 Recent Development
    11.5 Depomed
        11.5.1 Depomed Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.5.4 Opioids Drugs Product Description
        11.5.5 Recent Development
    11.6 INSYS
        11.6.1 INSYS Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.6.4 Opioids Drugs Product Description
        11.6.5 Recent Development
    11.7 Endo
        11.7.1 Endo Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.7.4 Opioids Drugs Product Description
        11.7.5 Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.8.4 Opioids Drugs Product Description
        11.8.5 Recent Development
    11.9 Hikma
        11.9.1 Hikma Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.9.4 Opioids Drugs Product Description
        11.9.5 Recent Development
    11.10 Mallinckrodt
        11.10.1 Mallinckrodt Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Opioids Drugs
        11.10.4 Opioids Drugs Product Description
        11.10.5 Recent Development
    11.11 Pernix
    11.12 Egalet
    11.13 Vistapharm

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Opioids Drugs Raw Material
        13.1.2 Opioids Drugs Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Opioids Drugs
    Figure Global Opioids Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Opioids Drugs Production Market Share by Types (Product Category) in 2017
    Figure Oxycodone Product Picture
    Table Major Manufacturers of Oxycodone
    Figure Hydromorphone Product Picture
    Table Major Manufacturers of Hydromorphone
    Figure Codeine Product Picture
    Table Major Manufacturers of Codeine
    Figure Fentanyl Product Picture
    Table Major Manufacturers of Fentanyl
    Figure Other Product Picture
    Table Major Manufacturers of Other
    Table Global Opioids Drugs Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Pain Relief
    Figure Anesthesia
    Figure Other
    Figure Opioids Drugs Report Years Considered
    Figure Global Opioids Drugs Market Size 2016-2025 (Million US$)
    Figure Global Opioids Drugs Sales 2016-2025 (K Units)
    Table Global Opioids Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Opioids Drugs Sales by Regions 2016-2025 (K Units)
    Table Global Opioids Drugs Sales Market Share by Regions 2016-2025
    Figure Global Opioids Drugs Sales Market Share by Regions 2016-2025
    Figure 2017 Global Opioids Drugs Sales Market Share by Regions
    Table Global Opioids Drugs Revenue by Regions 2016-2025 (Million US$)
    Table Global Opioids Drugs Revenue Market Share by Regions 2016-2025
    Figure Global Opioids Drugs Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Opioids Drugs Revenue Market Share by Regions
    Table Global Opioids Drugs Sales by Manufacturers (2016-2018) (K Units)
    Table Global Opioids Drugs Sales Share by Manufacturers (2016-2018)
    Figure Global Opioids Drugs Sales Share by Manufacturers in 2017
    Table Opioids Drugs Revenue by Manufacturers (2016-2018) (Million US$)
    Table Opioids Drugs Revenue Share by Manufacturers (2016-2018)
    Figure Opioids Drugs Value Share by Manufacturers in 2017
    Table Global Opioids Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Opioids Drugs Price (2016-2018) (USD/Unit)
    Table Opioids Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Opioids Drugs Product Category
    Table Date of International Manufacturers Enter into Opioids Drugs Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Opioids Drugs Sales by Type (2016-2025) (K Units)
    Table Global Opioids Drugs Sales Share by Type (2016-2025)
    Figure Global Opioids Drugs Sales Market Share by Type (2016-2025)
    Figure Global Opioids Drugs Sales Market Share by Type in 2017
    Table Global Opioids Drugs Revenue by Type (2016-2025) (Million US$)
    Table Global Opioids Drugs Revenue Share by Type (2016-2025)
    Figure Global Opioids Drugs Revenue Market Share by Type (2016-2025)
    Figure Global Opioids Drugs Revenue Market Share by Type in 2017
    Table Opioids Drugs Price by Type 2013-2018 (USD/Unit)
    Table Global Opioids Drugs Sales by Application (2016-2025) (K Units)
    Table Global Opioids Drugs Sales Share by Application (2016-2025)
    Figure Global Sales Opioids Drugs Market Share by Application (2016-2025)
    Figure Global Sales Opioids Drugs Market Share by Application (2016-2025)
    Figure North America Opioids Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure North America Opioids Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Opioids Drugs Sales by Countries (2016-2025) (K Units)
    Table North America Opioids Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Opioids Drugs Sales Market Share by Countries
    Table North America Opioids Drugs Revenue by Countries (2016-2025) (Million US$)
    Table North America Opioids Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Opioids Drugs Revenue Market Share by Countries
    Figure United States Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure United States Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Opioids Drugs Sales by Type (2016-2025) (K Units)
    Table North America Opioids Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 North America Opioids Drugs Market Share by Type
    Table North America Opioids Drugs Sales by Application (2016-2025) (K Units)
    Table North America Opioids Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 North America Opioids Drugs Market Share by Application
    Table North America Opioids Drugs Sales by Company (2016-2018) (K Units)
    Table North America Opioids Drugs Sales Market Share by Company (2016-2018)
    Figure North America Opioids Drugs Sales Market Share by Company in 2017
    Figure Europe Opioids Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Opioids Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Opioids Drugs Sales by Countries (2016-2025) (K Units)
    Table Europe Opioids Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Opioids Drugs Sales Market Share by Countries
    Table Europe Opioids Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Europe Opioids Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Opioids Drugs Revenue Market Share by Countries
    Figure Germany Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Opioids Drugs Revenue Growth Rate (2016-2025) (K Units)
    Figure France Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure France Opioids Drugs Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure UK Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Opioids Drugs Sales by Type (2016-2025) (K Units)
    Table Europe Opioids Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Opioids Drugs Market Share by Type
    Table Europe Opioids Drugs Sales by Application (2016-2025) (K Units)
    Table Europe Opioids Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Opioids Drugs Market Share by Application
    Table Europe Opioids Drugs Sales by Company (2016-2018) (K Units)
    Table Europe Opioids Drugs Sales Market Share by Company (2016-2018)
    Figure Europe Opioids Drugs Sales Market Share by Company in 2017
    Figure Asia Pacific Opioids Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Opioids Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Opioids Drugs Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Opioids Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Opioids Drugs Sales Market Share by Countries
    Table Asia Pacific Opioids Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Opioids Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Opioids Drugs Revenue Market Share by Countries
    Figure China Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure China Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure India Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Opioids Drugs Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Opioids Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Opioids Drugs Market Share by Type
    Table Asia Pacific Opioids Drugs Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Opioids Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Opioids Drugs Market Share by Application
    Table Asia Pacific Opioids Drugs Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Opioids Drugs Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Opioids Drugs Sales Market Share by Company in 2017
    Figure Central & South America Opioids Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Opioids Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Opioids Drugs Sales by Countries (2016-2025) (K Units)
    Table Central & South America Opioids Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Opioids Drugs Sales Market Share by Countries
    Table Central & South America Opioids Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Opioids Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Opioids Drugs Revenue Market Share by Countries
    Figure Brazil Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Opioids Drugs Sales by Type (2016-2025) (K Units)
    Table Central & South America Opioids Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Opioids Drugs Market Share by Type
    Table Central & South America Opioids Drugs Sales by Application (2016-2025) (K Units)
    Table Central & South America Opioids Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Opioids Drugs Market Share by Application
    Table Central & South America Opioids Drugs Sales by Company (2016-2018) (K Units)
    Table Central & South America Opioids Drugs Sales Market Share by Company (2016-2018)
    Figure Central & South America Opioids Drugs Sales Market Share by Company in 2017
    Figure Middle East and Africa Opioids Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Opioids Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Opioids Drugs Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Opioids Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Opioids Drugs Sales Market Share by Countries
    Table Middle East and Africa Opioids Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Opioids Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Opioids Drugs Revenue Market Share by Countries
    Figure GCC Countries Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Opioids Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Opioids Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Opioids Drugs Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Opioids Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Opioids Drugs Market Share by Type
    Table Middle East and Africa Opioids Drugs Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Opioids Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Opioids Drugs Market Share by Application
    Table Middle East and Africa Opioids Drugs Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Opioids Drugs Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Opioids Drugs Sales Market Share by Company in 2017
    Table Purdue Pharma Company Details
    Table Purdue Pharma Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Purdue Pharma Recent Development
    Table J&J Company Details
    Table J&J Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table J&J Recent Development
    Table Teva Company Details
    Table Teva Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Teva Recent Development
    Table Mylan Company Details
    Table Mylan Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Mylan Recent Development
    Table Depomed Company Details
    Table Depomed Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Depomed Recent Development
    Table INSYS Company Details
    Table INSYS Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table INSYS Recent Development
    Table Endo Company Details
    Table Endo Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Endo Recent Development
    Table Pfizer Company Details
    Table Pfizer Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Pfizer Recent Development
    Table Hikma Company Details
    Table Hikma Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Hikma Recent Development
    Table Mallinckrodt Company Details
    Table Mallinckrodt Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Mallinckrodt Recent Development
    Table Pernix Company Details
    Table Egalet Company Details
    Table Vistapharm Company Details
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Opioids Drugs Value Chain
    Table Typical Suppliers of Key Opioids Drugs Raw Material
    Table Opioids Drugs Customers List
    Table Opioids Drugs Sales Channels
    Table Opioids Drugs Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

03-Dec-2018 | Technology

Don’t await a 5G iPhone on or before 2020

Apple’s timeline for adopting the next generation of cellular connectivity, 5G, by suggesting the first compatible iPhone won’t come before 2020. Earlier rumors and reports pointed to t ...

31-Oct-2018 | Medical Care

Obesity, low BMI linked to increased risk of death, study reveals

The study, published Wednesday in The Lancet Diabetes and Endocrinology and conducted by scientists at London School of Hygiene and Tropical Medicine, revealed that BMI that's either too high o ...

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...

18-Jul-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

26-Jun-2018 | Electrical & Electronic Device

Vodafone to Make Stronger Enterprise Portfolio Thus Bolstering Global Telecom Market

Vodafone India is seeking at the broadband segment to fortify its venture portfolio, said the Sunil Sood, the MD and CEO of the telecom company. The carriers had posted 2x development in the enterp ...